CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Akorn Operating Company LLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Akorn Operating Company LLC
5605 CenterPoint Court
Phone: (847) 279-6100p:847 279-6100 Gurnee, IL  60031  United States Fax: (800) 943-3694f:800 943-3694

Filed for Bankruptcy on 2/23/2023
This company ceased filing statements with the SEC on 10/2/2020.
Case #23-10255, filed in the U.S. Bankruptcy Court for the District of Delaware (Chapter 7)
The Company has ceased operations.
This company is no longer actively traded on any major stock exchange.

Business Summary
Akorn Operating Company LLC, formerly known as Akorn, Inc., is a specialty generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as private-label over-the-counter (OTC) consumer health products and animal health pharmaceuticals. The Company operates through two segments: Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment consists of generic and branded prescription pharmaceuticals in a range of dosage forms, including sterile ophthalmics, injectables and inhalants and non-sterile oral liquids, topicals and nasal sprays and otics. The Consumer Health segment consists of branded and private-label OTC products and animal health products dispensed by veterinary professionals. Its branded and private-label OTC products are focused on ophthalmics, including a dry eye treatment, TheraTears Therapy for Your Eyes.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
--YesYesYes--

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
--YesYesYesYesYes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board Alan D.Weinstein 76 10/30/2017 7/1/2009
President, Chief Executive Officer, Director Douglas S.Boothe 55 1/28/2019 1/1/2019
Chief Financial Officer, Executive Vice President Duane A.Portwood 52 10/30/2015 10/30/2015
10 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
AKORN, INC.
Akorn AG Riethofstrasse 1 Hettlingen Switzerland
Akorn Animal Health Inc. 1925 West Field Court Lake Forest IL United States
3 additional Subsidiary records available in full report.

Business Names
Business Name
10 Edison Street LLC
10 Edison Street LLC
13 Edison Street LLC
49 additional Business Names available in full report.

General Information
Stock Exchange: OTC
Federal Tax Id: 852826184
Fax Number: (800) 943-3694


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, March 26, 2024